Cochlear Financials

COH Stock   301.56  3.33  1.12%   
We suggest to use Cochlear fundamental analysis to see if markets are presently undervaluing or overvaluing the company. Put another way, you can use it to find out if Cochlear is indeed mispriced or if you can make any profits on it by purchasing it and then waiting for the market to recognize its mistake and reprise the security. We have analyze and collected data for thirty available fundamental indicators for Cochlear, which can be compared to its peers. The stock experiences a large bullish trend. Check odds of Cochlear to be traded at 331.72 in 90 days. Key indicators impacting Cochlear's financial strength include:
Current ValueLast YearChange From Last Year 10 Year Trend
Operating Income547.6 M521.5 M
Sufficiently Up
Slightly volatile
  
Understanding current and past Cochlear Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Cochlear's financial statements are interrelated, with each one affecting the others. For example, an increase in Cochlear's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Cochlear's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Cochlear. Check Cochlear's Beneish M Score to see the likelihood of Cochlear's management manipulating its earnings.

Cochlear Stock Summary

Cochlear competes with Credit Clear, Finexia Financial, Westpac Banking, Macquarie Bank, and National Australia. Cochlear is entity of Australia. It is traded as Stock on AU exchange.
Foreign Associate
  USA
Specialization
Health Care, Health Care Equipment & Services
InstrumentAustralia Stock View All
ExchangeAustralian Securities Exchange
ISINAU000000COH5
Business Address1 University Avenue,
SectorHealth Care Equipment & Supplies
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitewww.cochlear.com
Phone61 2 9428 6555
You should never invest in Cochlear without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Cochlear Stock, because this is throwing your money away. Analyzing the key information contained in Cochlear's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.

Cochlear Key Financial Ratios

Cochlear's financial ratios allow both analysts and investors to convert raw data from Cochlear's financial statements into concise, actionable information that can be used to evaluate the performance of Cochlear over time and compare it to other companies across industries.

Cochlear Key Balance Sheet Accounts

201920202021202220232024 (projected)
Total Assets2.6B2.4B2.5B2.6B2.7B2.9B
Other Current Liab192.1M112M146.6M189.3M202.4M212.5M
Net Debt139.5M(345.3M)(375.4M)(353.7M)(269.9M)(256.4M)
Retained Earnings116.4M355.1M455.3M555.4M667.9M701.3M
Accounts Payable159.3M202.9M232.4M270.4M303.2M318.4M
Cash565M609.6M629.3M555.5M513.6M539.3M
Net Receivables304.9M296.3M390.4M457.5M502M527.1M
Inventory223.8M216.1M270.2M311.5M391.6M411.2M
Other Current Assets18.8M38.8M37.1M37M44.9M23.8M
Total Liab1.2B736.5M779.4M819.9M904.6M949.8M
Total Current Assets1.5B1.2B1.3B1.4B1.5B1.5B
Short Term Debt419.1M31.9M78.7M39.2M41.6M55.6M
Common Stock182.3M1.3B1.3B1.3B1.2B1.3B
Other Liab71.3M101.6M76.6M79.3M91.2M48.0M
Other Assets212.3M203.4M220.3M1.01.151.09
Intangible Assets410.3M385.5M392.5M444.1M193.3M143.5M
Good Will270.9M267.3M257.1M256.1M257.7M219.4M
Short Long Term Debt3.7M3.3M393.1M42.6M38.3M36.4M
Net Tangible Assets1.0B1.4B1.3B1.3B1.5B840.2M
Long Term Debt Total285.4M232.4M175.2M162.6M187.0M206.4M

Cochlear Key Income Statement Accounts

201920202021202220232024 (projected)
Interest Expense10.5M12M8.6M9.4M9.2M6.8M
Total Revenue1.4B1.5B1.6B2.0B2.3B2.4B
Gross Profit1.0B1.1B1.2B1.5B1.7B1.8B
Operating Income259M327.9M361.7M412.4M521.5M547.6M
Ebit259M375.5M402.4M406.2M494.6M519.3M
Research Development185.1M195M210.7M244.9M277M290.9M
Ebitda336.5M451.9M475.4M487.1M579.5M608.5M
Income Before Tax(269.9M)363.5M393.8M396.8M485.4M509.7M
Net Income(238.3M)326.5M289.1M300.6M356.8M374.6M
Income Tax Expense(32.8M)38M104.7M96M128M134.4M
Cost Of Revenue344.4M410.2M411M488M562.1M590.2M
Tax Provision(32.8M)39.2M104.7M96M128M81.0M
Net Interest Income(10.5M)(8.4M)(6.2M)7.1M9.8M10.3M
Interest Income8.9M3.6M2.4M7.1M19M20.0M

Cochlear Key Cash Accounts

201920202021202220232024 (projected)
Change In Cash486.4M44.6M19.7M(73.8M)(41.9M)(39.8M)
Free Cash Flow(288.3M)198.7M299.3M266.5M299M314.0M
Depreciation77.5M76.4M73M80.9M84.9M89.1M
Other Non Cash Items(30.7M)(51.7M)(18.4M)7.4M463.4M486.6M
Dividends Paid193.7M75.6M194M197.4M245.7M258.0M
Capital Expenditures130.5M66.7M77.2M95.9M89.8M94.3M
Net Income(238.3M)323.8M289.1M300.6M356.8M374.6M
End Period Cash Flow565M609.6M629.3M555.5M513.6M539.3M
Change To Inventory(28.4M)7.7M(54.1M)(41.3M)(80.1M)(76.1M)
Investments(379.2M)346.6M(61.7M)(125.7M)(105.7M)(100.4M)
Net Borrowings266.3M(421.9M)(25.6M)(72.7M)(65.4M)(62.2M)
Change To Netincome(23.7M)(43.6M)(7.6M)23.3M21.0M22.0M

Cochlear Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Cochlear's current stock value. Our valuation model uses many indicators to compare Cochlear value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Cochlear competition to find correlations between indicators driving Cochlear's intrinsic value. More Info.
Cochlear is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about  0.60  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Cochlear is roughly  1.66 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Cochlear's earnings, one of the primary drivers of an investment's value.

Cochlear Systematic Risk

Cochlear's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Cochlear volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Execute Function
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Cochlear correlated with the market. If Beta is less than 0 Cochlear generally moves in the opposite direction as compared to the market. If Cochlear Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Cochlear is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Cochlear is generally in the same direction as the market. If Beta > 1 Cochlear moves generally in the same direction as, but more than the movement of the benchmark.

Cochlear Total Assets Over Time

Cochlear November 26, 2024 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Cochlear help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Cochlear. We use our internally-developed statistical techniques to arrive at the intrinsic value of Cochlear based on widely used predictive technical indicators. In general, we focus on analyzing Cochlear Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Cochlear's daily price indicators and compare them against related drivers.

Additional Tools for Cochlear Stock Analysis

When running Cochlear's price analysis, check to measure Cochlear's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cochlear is operating at the current time. Most of Cochlear's value examination focuses on studying past and present price action to predict the probability of Cochlear's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cochlear's price. Additionally, you may evaluate how the addition of Cochlear to your portfolios can decrease your overall portfolio volatility.